Multiple Manufacturers

NUWIQ

Manufacturer:

Multiple Manufacturers

Nuwiq HCPCS:

J7209

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.

Category:

J Code

Nuwiq NDCs:

68982-0153-01, 68982-0152-01, 68982-0148-01, 68982-0151-01, 68982-0149-01, 68982-0150-01, 68982-0146-01, 68982-0147-01, 68982-0144-01, 68982-0142-01, 68982-0143-01, 68982-0145-01, 68982-0141-01, 68982-0140-01, 68982-0139-01

Primary Type:

Hematology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Nuwiq:

NUWIQ is a Hematology drug manufactured by Octapharma and administered via the Intravenous route of administration. The J Code: J7209 is aligned to the drug NUWIQ.

ACCESS PRICING AND MORE BY REGISTERING

J7209 Added Date:

January 1, 2017

J7209 Effective Date:

January 1, 2017

J7209 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Nuwiq billing and coding information.
Nuwiq patient assistance information can be found through Octapharma Patient Assistance at the URL: https://nuwiqusa.com/patient-support/co-pay-assistance-reimbursement/
NUWIQ prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for NUWIQ. Please check back in a few weeks.